Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MDRX 
Veradigm Inc. (MDRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MDRX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -32.03% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 460.13M USD | Price to earnings Ratio - | 1Y Target Price 10 |
Price to earnings Ratio - | 1Y Target Price 10 | ||
Volume (30-day avg) 216897 | Beta 0.56 | 52 Weeks Range 4.00 - 11.80 | Updated Date 04/2/2025 |
52 Weeks Range 4.00 - 11.80 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.7% | Operating Margin (TTM) 16.59% |
Management Effectiveness
Return on Assets (TTM) -0.64% | Return on Equity (TTM) -1.69% |
Valuation
Trailing PE - | Forward PE 15.17 | Enterprise Value 232975842 | Price to Sales(TTM) 0.78 |
Enterprise Value 232975842 | Price to Sales(TTM) 0.78 | ||
Enterprise Value to Revenue 0.4 | Enterprise Value to EBITDA 3.99 | Shares Outstanding 108265000 | Shares Floating 88165525 |
Shares Outstanding 108265000 | Shares Floating 88165525 | ||
Percent Insiders 2.91 | Percent Institutions 40.11 |
Analyst Ratings
Rating 3.75 | Target Price 12.75 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Veradigm Inc.
Company Overview
History and Background
Veradigm Inc. was formerly known as Allscripts Healthcare Solutions, Inc. The company was founded in 1986. Significant milestones include the merger of Allscripts and Misys Healthcare Systems in 2008 and the rebranding to Veradigm in 2018, focusing on data and analytics.
Core Business Areas
- Provider Solutions: Provides electronic health record (EHR) solutions, practice management systems, and other clinical and financial applications for healthcare providers.
- Payer Solutions: Offers solutions for payers, including data analytics, risk management, and value-based care programs.
- Life Sciences Solutions: Delivers data and insights to pharmaceutical and biotech companies to improve drug development, commercialization, and patient outcomes.
Leadership and Structure
The leadership team includes the CEO, CFO, and other key executives. The organizational structure includes various divisions focused on different business segments, such as provider solutions, payer solutions, and life sciences solutions.
Top Products and Market Share
Key Offerings
- Sunrise EHR: A comprehensive electronic health record system used by hospitals and large healthcare organizations. Competitors include Epic Systems and Cerner (Oracle). Market share data specific to Sunrise EHR alone is not readily available, but Veradigm's overall EHR market share is estimated in the single-digit percentages.
- Professional EHR: An EHR system designed for physician practices and ambulatory care settings. Competitors include athenahealth and eClinicalWorks. Market share data specific to Professional EHR alone is not readily available, but Veradigm's overall EHR market share is estimated in the single-digit percentages.
- Accuity: A suite of analytics and risk management solutions for payers. Competitors include Optum and Cognizant. Revenue from Accuity is not publicly broken out.
- Veradigm Network: Provides solutions that connect payers, biopharma, healthcare providers and patients to enhance collaboration and the overall healthcare experience. Competitors include Komodo Health, Innovaccer. Revenue from the Veradigm Network is not publicly broken out.
Market Dynamics
Industry Overview
The healthcare IT industry is experiencing growth due to the increasing adoption of EHRs, the need for data analytics, and the shift towards value-based care. The industry is competitive, with many established players and emerging startups.
Positioning
Veradigm Inc. is positioned as a provider of integrated solutions for healthcare providers, payers, and life sciences companies. Its competitive advantages include its broad portfolio of products and its focus on data and analytics.
Total Addressable Market (TAM)
The total addressable market for healthcare IT is estimated to be in the hundreds of billions of dollars. Veradigm Inc. is positioned to capture a portion of this market by offering comprehensive solutions across various segments.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Established customer base
- Focus on data and analytics
- Strong brand recognition
Weaknesses
- Integration challenges
- Competition from larger players
- Inconsistent profitability
- Past security breaches
Opportunities
- Growing demand for telehealth solutions
- Increasing adoption of value-based care
- Expansion into new markets
- Strategic acquisitions
Threats
- Intense competition
- Regulatory changes
- Cybersecurity threats
- Economic downturn
Competitors and Market Share
Key Competitors
- ORCL
- ATHN
- MTBC
Competitive Landscape
Veradigm Inc. faces intense competition from larger and more established players. Its competitive advantages include its broad product portfolio and its focus on data and analytics. Its disadvantages include its smaller size and inconsistent profitability.
Major Acquisitions
Allscripts EPSi
- Year: 2020
- Acquisition Price (USD millions): 365
- Strategic Rationale: Enhanced Veradigm's analytics and financial performance management capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is dependent on financial reporting. Historically the Company has experienced slow growth overall and some periods of decline
Future Projections: Future growth is dependent on analyst reports. This should be looked up.
Recent Initiatives: Recent initiatives include strategic acquisitions, product enhancements, and expansion into new markets.
Summary
Veradigm is positioned in the healthcare IT space with a suite of solutions for providers, payers, and life sciences. It has a broad portfolio but struggles with profitability and integration challenges. Opportunities exist in telehealth and value-based care, but intense competition and regulatory changes pose threats. The company's focus on data and analytics is a key strength, but inconsistent financial performance needs addressing for long-term success.
Similar Companies
ORCL
Oracle Corporation
ORCL
Oracle Corporation
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Market research reports
- Analyst reports
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may vary. Financial data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veradigm Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 1999-07-26 | CEO - | ||
Sector Healthcare | Industry Health Information Services | Full time employees 2450 | Website https://veradigm.com |
Full time employees 2450 | Website https://veradigm.com | ||
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.